This study aims to further validate and extend our previous findings insofar that the effect of the atypical antipsychotic and mixed 5-HT2/D2 antagonist sertindole on sensorimotor gating processes and its relationship to cognitive performance shall be explored.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Enrollment
30
oral 3 x 4mg
3 x 4mg Placebo
University of Psychiatry Hospital
Zurich, Canton of Zurich, Switzerland
Sensory (EEG: P50 suppression) and sensorimotor gating (EMG: PPI)
Time frame: after placebo and and after medical treatment
Cognitive performances
Time frame: after placebo and and after medical treatment
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.